Skip to main content

Advertisement

SpringerLink
Log in

Effect of Fibroblast-Like Cells of Mesenchymal Origin of Cytotoxic Activity of Lymphocytes against NK-Sensitive Target Cells

  • Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied immunosuppressive properties of skin fibroblasts and mesenchymal stromal cells against NK cells. In vitro experiments showed that mesenchymal stromal cells isolated from human umbilical cord and human skin fibroblasts can considerably attenuate cytotoxic activity of NK cells against Jurkat cells sensitive to NK-mediated lysis. NK cells cultured in lymphocyte population exhibited higher cytotoxic activity than isolated NK cells. Mesenchymal stromal cells or fibroblasts added 1:1 to lymphocyte culture almost completely suppressed NK cell cytotoxicity. This suggests that fibroblast-like cells can suppress not only isolated NK cells, but also NK cells in natural cell microenvironment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abakushina EV, Kuzmina EG, Kovalenko EI. The main characteristics of human natural killer cells. Immunologiya. 2012;33(4):220-224. Russian.

    CAS  Google Scholar 

  2. Vdovin AS, Lupatov AY, Kholodenko IV, Yarygin KN. Comparison of the efficiency of viral transduction and episomal transfection in human fibroblast reprogramming. Bull. Exp. Biol. Med. 2015;160(1):123-128.

    Article  CAS  PubMed  Google Scholar 

  3. Lupatov AY, Vdovin AS, Vakhrushev IV, Poltavtseva RA, Yarygin KN. Comparative analysis of the expression of surface markers on fibroblasts and fibroblast-like cells isolated from different human tissues. Bull. Exp. Biol. Med. 2015;158(4):537-543.

    Article  CAS  PubMed  Google Scholar 

  4. Lupatov AY, Karalkin PA, Suzdal’tseva YG, Burunova VV, Yarygin VN, Yarygin KN. Cytofluorometric analysis of phenotypes of human bone marrow and umbilical fibroblast-like cells. 2006;142(4):521-526.

  5. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815-1822.

    Article  CAS  PubMed  Google Scholar 

  6. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002;30(1):42-48.

    Article  PubMed  Google Scholar 

  7. Blasi A, Martino C, Balducci L, Saldarelli M, Soleti A, Navone S.E, Canzi L, Cristini S, Invernici G, Parati E.A, Alessandri G. Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc. Cell. 2011;3(1):5. doi: 10.1186/2045-824X-3-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3(4):e1886.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Chen L, Zhang W, Yue H, Han Q, Chen B, Shi M, Li J, Li B, You S, Shi Y, Zhao R.C. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev. 2007;16(5):719-731.

    Article  CAS  PubMed  Google Scholar 

  10. Chen Y, Perussia B, Campbell KS. Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. J. Immunol. 2007;179(5):2766-2773.

    Article  CAS  PubMed  Google Scholar 

  11. DelaRosa O, Sánchez-Correa B, Morgado S, Ramírez C, del Río B, Menta R, Lombardo E, Tarazona R, Casado JG. Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev. 2011;21(8):1333-1343.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ghannam S, Pène J, Moquet-Torcy G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentia-tion and function and induce a T regulatory cell phenotype. J. Immunol. 2010;185(1):302-312.

    Article  CAS  PubMed  Google Scholar 

  13. Götherström C, Lundqvist A, Duprez IR, Childs R, Berg L, le Blanc K. Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways. Cytotherapy. 2011;13(3):269-278.

    Article  PubMed  Google Scholar 

  14. Jorgensen C, Djouad F, Apparailly F, Noël D. Engineering mesenchymal stem cells for immunotherapy. Gene Ther. 2003;10(10):928-931.

    Article  CAS  PubMed  Google Scholar 

  15. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24(2):386-398.

    Article  CAS  PubMed  Google Scholar 

  16. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003;5(6):485-489.

    Article  PubMed  Google Scholar 

  17. Poggi A, Prevosto C, Massaro A.M, Negrini S, Urbani S, Pierri I, Saccardi R, Gobbi M, Zocchi M.R. Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors. J. Immunol. 2005;175(10):6352-6360.

    Article  CAS  PubMed  Google Scholar 

  18. Rasmusson I, Le Blanc K, Sundberg B, Ringdén O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand. J. Immunol. 2007;65(4):336-343.

    Article  CAS  PubMed  Google Scholar 

  19. Rasmusson I, Uhlin M, Le Blanc K, Levitsky V. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J. Leukoc. Biol. 2007;82(4):887-893.

    Article  CAS  PubMed  Google Scholar 

  20. Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol. 2007;149(2):353-363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006;24(1):74-85.

    Article  PubMed  Google Scholar 

  22. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood. 2009;113(26):6576-6583.

    Article  CAS  PubMed  Google Scholar 

  23. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008;111(3):1327-1333.

    Article  CAS  PubMed  Google Scholar 

  24. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK cell proliferation. Blood. 2006;107(4):1484-1490.

    Article  CAS  PubMed  Google Scholar 

  25. Thomas H, Jäger M, Mauel K, Brandau S, Lask S, Flohé S.B. Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12/IL-18-induced interferon-gamma secretion. Mediators Inflamm. 2014;2014. ID 143463. doi: 10.1155/2014/143463. http://dx.doi.org/10.1155/2014/143463.

  26. Tu Z, Li Q, Bu H, Lin F. Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev. 2010;19(11):1803-1809.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Vallera DA, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl JU, Zhang B, Lenvik AJ, Panoskaltsis-Mortari A, Verneris MR, Tolar J, Cooley S, Weisdorf DJ, Blazar BR, Miller JS. IL15 trispecific killer engagers (TriKE) make natural killer cells specific to CD33+ targets while also inducing persistence, in vivo expansion, and enhanced function. Clin. Cancer Res. 2016;22(14):3440-3450.

    Article  CAS  PubMed  Google Scholar 

  28. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 1998;188(12):2375-2380.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. V. N. Orekhovich Research Institute of Biomedical Chemistry, Moscow, Russia

    A. Yu. Lupatov, Ya. S. Kim, I. V. Vakhrushev, K. N. Yarygin & G. T. Sukhikh

  2. V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation, Moscow, Russia

    A. Yu. Lupatov, Ya. S. Kim, O. A. Bystrykh, I. V. Vakhrushev, S. V. Pavlovich, K. N. Yarygin & G. T. Sukhikh

Authors
  1. A. Yu. Lupatov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ya. S. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. A. Bystrykh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. V. Vakhrushev
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. V. Pavlovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. N. Yarygin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. T. Sukhikh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Yu. Lupatov.

Additional information

Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 4, pp. 241-244, October, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lupatov, A.Y., Kim, Y.S., Bystrykh, O.A. et al. Effect of Fibroblast-Like Cells of Mesenchymal Origin of Cytotoxic Activity of Lymphocytes against NK-Sensitive Target Cells. Bull Exp Biol Med 162, 552–557 (2017). https://doi.org/10.1007/s10517-017-3658-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3658-5

Key Words

Search

Navigation